A new study from the PARADIGM-HF and PARAGON-HF clinical trials found that sacubitril/valsartan significantly reduced the ...

Sacubitril/valsartan or Sac/Val was launched in the US in July 2015, under brand name Entresto and in five European markets ...

Medicare Part D provides coverage for Entresto. Learn more about Medicare drug coverage and the costs of Entresto.

Biotechnology firm Biocon said its subsidiary has received approval from the US health regulator to market a generic ...

Even trace amounts of impurities in medication can spell trouble. Yet, recent research shows that nearly one-third of ...

Biocon Chairperson Kiran Mazumdar-Shaw on Thursday called for more investment in research and development to drive innovation ...

The USFDA has also approved Biocon Limited subsidiary's ANDA for Daptomycin for Injection (500mg Vial) for skin infections.

Pay a tax of up to 1,900% (not 95%) on the total sales revenue of the medicine selected for price setting. News coverage ...

Bayer's mineralocorticoid receptor antagonist (MRA) Kerendia hit the mark as a treatment for a common form of heart failure ...

Q4 2024 Earnings Call Transcript August 28, 2024 Operator: Hello and welcome to the Mesoblast Financial Results for the Full ...

Biocon has received approval for its generic drug to treat chronic heart failure. The medicine can be used both for adults ...